INFLAMMATORY CARCINOMA OF THE BREAST

This adverse event was reported 145 times

These drugs are most commonly taken by patients reporting INFLAMMATORY CARCINOMA OF THE BREAST:

# Drug Count
0 CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE 10
1 INTERFERON BETA-1A 10
2 TRASTUZUMAB 10
3 ADALIMUMAB 8
4 DOCETAXEL 8
5 DOCETAXEL ANHYDROUS 8
6 ETANERCEPT 7
7 GABAPENTIN 7
8 INFLIXIMAB 7
9 LEVOTHYROXINE SODIUM 7
See all common drugs associated with INFLAMMATORY CARCINOMA OF THE BREAST